Bionano Genomics Q1 Sales $6.50M Beat $6.23M Estimate

Bionano Genomics (NASDAQ: BNGO) reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.23 million by 4.28 percent. This is a 25.88 percent decrease over sales of $8.77 million the same period last year.